Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Inivata
3151
Inivata
Technology
Biotechnology
A clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis to improve testing and treatment for oncologists and patients.
Suggest edits
Founded
2014
Raised
$105.5M
Follow us
Also headquartered in Cambridge
MIT
Raspberry Pi
ARM
Xconomy
Biogen
Money Mover
HubSpot
Formlabs
Akamai
General Catalyst
Companies in the same industry
Genkyotex S.A
Putney, Inc.
Intercept Pharmaceuticals
Cardiovascular Systems, Inc.
CTI BioPharma
Xeris Pharmaceuticals
Momenta Pharmaceuticals
Vensun Pharmaceuticals
Idera Pharmaceuticals
Aegerion Pharmaceuticals
Alexa global traffic share
Twitter followers
Overview
Funding
3
Add info
Latest funding
Show all
$52,600,000
Venture capital (Series B) - 2019
Johnson & Johnson Innovation
Cambridge Innovation Capital
Woodford Patient Capital Trust
+1
£31,500,000
Venture capital (Series A) - 2016
Imperial Innovations
Johnson & Johnson Innovation
Cambridge Innovation Capital
+1
Team Size
10+
Employees
I work here
Location
Cambridge
,
United States
Headquarters
Explore Cambridge
$52,600,000
Venture capital (Series B)
PE HUB
Inivata snags $52.6 mln Series B
FinSMEs
Inivata Completes $52.6m Series B Funding
£31,500,000
Venture capital (Series A)
FinSMEs
Inivata Completes £31.5M Series A Funding
Health
Funding
Science
